{{Rsnum
|rsid=2275351
|Gene=CHI3L1
|Chromosome=1
|position=203180945
|Orientation=plus
|GMAF=0.343
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CHI3L1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 60.7 | 36.1 | 3.3
| HCB | 37.2 | 51.2 | 11.6
| JPT | 29.5 | 40.9 | 29.5
| YRI | 19.0 | 47.6 | 33.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 37.2 | 51.2 | 11.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|18281018}}  [[schizophrenia]]
*375 case and 812 control subjects
*[[rs10399805]] p = .018 and [[rs2275351]]; p = .008.

{{PharmGKB
|RSID=rs2275351
|Name_s=
|Gene_s=CHI3L1, MYBPH
|Feature=
|Evidence=PubMed ID:18281018
|Annotation=In a sample of 375 case and 812 control subjects a significant association of schizophrenia with this SNP (rs2275351) at intron 7 of CHI3L1 was identified.
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Curated
|PharmGKB Accession ID=PA162565808
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2275351
|overall_frequency_n=40
|overall_frequency_d=128
|overall_frequency=0.3125
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=36
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}